Latest News

narcolepsy
Positive Phase 2 Data: Alixorexton for the Treatment of Adults With Narcolepsy Type 1

July 21st 2025

Positive phase 2 results show that treatment with alixorexton led to statistically significant and dose-dependent improvements in sleep latency among patients with narcolepsy type 1.

sleep
What Is a Sleep Disorder? A Harmful Dysfunction Analysis

June 24th 2025

night
Beyond the Night: Unraveling the Psychiatric Impact of Sleep Disorders

June 23rd 2025

insomnia
Promoting Insomnia Management in the Context of Psychiatric Symptoms

June 20th 2025

sleep
The Overlap in Sleep Problems and Psychiatric Disorders

June 19th 2025

Video Interviews
Podcasts
Latest CME Events & Activities

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

Southern Florida Psychiatry Conference

November 21-22, 2025

Register Now!

Real Psychiatry 2026

January 23-24, 2026

View More

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

View More

Optimizing Care for Patients With Tardive Dyskinesia

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

More News

© 2025 MJH Life Sciences

All rights reserved.